SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Equillium, Inc. (EQ) has a negative trailing P/E of -7.7, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -13.04%.
Criteria proven by this page:
- VALUE (10/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E -7.7); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -13.04%); analyst consensus target implies downside from the current price ($1.00, 51.2%).
- Trailing Earnings Yield -13.04% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.
- Analyst consensus target $1.00 (-51.2% downside) — analysts see meaningful downside risk at the current price level.
Overall SharesGrow Score: 37/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
10/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — EQ
Valuation Multiples
P/E (TTM)-7.7
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio6.01
P/S Ratio0.00
EV/EBITDA-1.6
Per Share Data
EPS (TTM)$-0.24
Book Value / Share$0.31
Revenue / Share$0.00
FCF / Share$-0.25
Yields & Fair Value
Earnings Yield-13.04%
Dividend Yield0.00%
Analyst Target$1.00 (-51.2%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2017 |
-72.3 |
0.00 |
-72.60 |
0.00 |
- |
| 2018 |
-7.5 |
-0.01 |
1.53 |
0.00 |
- |
| 2019 |
-2.3 |
-0.07 |
1.40 |
0.00 |
- |
| 2020 |
-3.7 |
5.37 |
1.56 |
0.00 |
- |
| 2021 |
-2.8 |
0.37 |
1.63 |
0.00 |
- |
| 2022 |
-0.6 |
0.00 |
1.12 |
2.27 |
- |
| 2023 |
-1.9 |
0.02 |
1.11 |
0.70 |
- |
| 2024 |
-3.3 |
0.08 |
1.39 |
0.64 |
- |
| 2025 |
-6.4 |
-0.09 |
4.98 |
1,095.50 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2017 |
$-0.13 |
$0.00 |
$-2.26M |
- |
| 2018 |
$-1.09 |
$0.00 |
$-13.25M |
- |
| 2019 |
$-1.47 |
$0.00 |
$-25.58M |
- |
| 2020 |
$-1.46 |
$0.00 |
$-29.77M |
- |
| 2021 |
$-1.35 |
$0.00 |
$-38.98M |
- |
| 2022 |
$-3.19 |
$15.76M |
$-107.71M |
-683.5% |
| 2023 |
$-0.38 |
$36.08M |
$-13.34M |
-37% |
| 2024 |
$-0.23 |
$41.1M |
$-8.07M |
-19.6% |
| 2025 |
$-0.39 |
$130K |
$-22.4M |
-17229.2% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$-0.20 |
$-0.20 – $-0.19 |
$15.58M |
$15.58M – $15.58M |
2 |
| 2027 |
$-0.21 |
$-0.21 – $-0.20 |
$16.52M |
$16.52M – $16.52M |
3 |
| 2028 |
$-0.27 |
$-0.32 – $-0.22 |
$51.69M |
$51.69M – $51.69M |
3 |
| 2029 |
$-0.29 |
$-0.29 – $-0.29 |
$89.24M |
$89.24M – $89.24M |
1 |
| 2030 |
$-0.37 |
$-0.37 – $-0.37 |
$154.78K |
$154.78K – $154.78K |
1 |
